BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28209015)

  • 1. Boron Neutron Capture Therapy - A Literature Review.
    Nedunchezhian K; Aswath N; Thiruppathy M; Thirugnanamurthy S
    J Clin Diagn Res; 2016 Dec; 10(12):ZE01-ZE04. PubMed ID: 28209015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Boron neutron capture therapy of brain tumors: an emerging therapeutic modality.
    Barth RF; Soloway AH; Goodman JH; Gahbauer RA; Gupta N; Blue TE; Yang W; Tjarks W
    Neurosurgery; 1999 Mar; 44(3):433-50; discussion 450-1. PubMed ID: 10069580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron neutron capture therapy of brain tumors: past history, current status, and future potential.
    Barth RF; Soloway AH; Brugger RM
    Cancer Invest; 1996; 14(6):534-50. PubMed ID: 8951358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The basis and advances in clinical application of boron neutron capture therapy.
    He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
    Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Boron neutron capture therapy for cancer. Realities and prospects.
    Barth RF; Soloway AH; Fairchild RG; Brugger RM
    Cancer; 1992 Dec; 70(12):2995-3007. PubMed ID: 1451084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy.
    Hartman T; Carlsson J
    Radiother Oncol; 1994 Apr; 31(1):61-75. PubMed ID: 8041899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boron neutron capture therapy of cancer: current status and future prospects.
    Barth RF; Coderre JA; Vicente MG; Blue TE
    Clin Cancer Res; 2005 Jun; 11(11):3987-4002. PubMed ID: 15930333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy.
    Wu G; Barth RF; Yang W; Lee RJ; Tjarks W; Backer MV; Backer JM
    Anticancer Agents Med Chem; 2006 Mar; 6(2):167-84. PubMed ID: 16529539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of the high-LET radiations from the boron neutron capture [10B(n,α) 7Li] reaction determined for induction of chromosome aberrations and apoptosis in lymphocytes of human blood samples.
    Schmid TE; Canella L; Kudejova P; Wagner FM; Röhrmoser A; Schmid E
    Radiat Environ Biophys; 2015 Mar; 54(1):91-102. PubMed ID: 25428113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boron Neutron Capture Therapy for Malignant Brain Tumors.
    Miyatake S; Kawabata S; Hiramatsu R; Kuroiwa T; Suzuki M; Kondo N; Ono K
    Neurol Med Chir (Tokyo); 2016 Jul; 56(7):361-71. PubMed ID: 27250576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of boron neutron capture therapy (BNCT) and the design and dosimetry of a high-intensity, 24 keV, neutron beam for BNCT research.
    Perks CA; Mill AJ; Constantine G; Harrison KG; Gibson JA
    Br J Radiol; 1988 Dec; 61(732):1115-26. PubMed ID: 3064858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The New Generation of Particle Therapy Focused on Boron Element (Boron Neutron Capture Therapy; BNCT) -The World's First Approved BNCT Drug].
    Nakashima H
    Yakugaku Zasshi; 2022; 142(2):155-164. PubMed ID: 35110452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
    Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The radiation biology of boron neutron capture therapy.
    Coderre JA; Morris GM
    Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boron neutron capture therapy of primary and metastatic brain tumors.
    Barth RF; Soloway AH
    Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte Carlo based protocol for cell survival and tumour control probability in BNCT.
    Ye SJ
    Phys Med Biol; 1999 Feb; 44(2):447-61. PubMed ID: 10070794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geant4 beam model for boron neutron capture therapy: investigation of neutron dose components.
    Moghaddasi L; Bezak E
    Australas Phys Eng Sci Med; 2018 Mar; 41(1):129-141. PubMed ID: 29362987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Boron neutron capture therapy for malignant gliomas.
    Diaz AZ; Coderre JA; Chanana AD; Ma R
    Ann Med; 2000 Feb; 32(1):81-5. PubMed ID: 10711581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Review of Boron Neutron Capture Therapy: Its History and Current Challenges.
    Jin WH; Seldon C; Butkus M; Sauerwein W; Giap HB
    Int J Part Ther; 2022; 9(1):71-82. PubMed ID: 35774489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Boron neutron capture therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor.
    Fukuda H; Hiratsuka J; Kobayashi T; Sakurai Y; Yoshino K; Karashima H; Turu K; Araki K; Mishima Y; Ichihashi M
    Australas Phys Eng Sci Med; 2003 Sep; 26(3):97-103. PubMed ID: 14626847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.